Shanghai Financial Statements From 2010 to 2024

Stocks China . 
Stock . Shanghai Pharmaceuticals Holding
601607 Stock   21.75  0.07  0.32%   
Shanghai Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Shanghai Pharmaceuticals Holding investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Shanghai Pharmaceuticals financial statements helps investors assess Shanghai Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Shanghai Pharmaceuticals' valuation are summarized below:
Gross Profit
28.4 B
Profit Margin
0.0148
Market Capitalization
71.7 B
Enterprise Value Revenue
0.2914
Revenue
272.4 B
We have found seventy-nine available fundamental trend indicators for Shanghai Pharmaceuticals Holding, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Shanghai Pharmaceuticals Holding current market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Shanghai Pharmaceuticals Total Revenue

273.31 Billion

Check Shanghai Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 1.7 B, Selling General Administrative of 16.4 B or Total Revenue of 273.3 B, as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Shanghai Pharmaceuticals Technical models . Check out the analysis of Shanghai Pharmaceuticals Correlation against competitors.

Shanghai Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets222.6 B212 B112.2 B
Slightly volatile
Other Current Liabilities3.5 B6.3 B4.9 B
Slightly volatile
Total Current Liabilities128.5 B122.4 B61.2 B
Slightly volatile
Total Stockholder Equity72 B68.5 B38.7 B
Slightly volatile
Retained Earnings35.5 B33.8 B19.1 B
Slightly volatile
Accounts Payable57.4 B54.6 B30.6 B
Slightly volatile
Cash32 B30.5 B17.4 B
Slightly volatile
Other Assets3.7 B3.5 B2.3 B
Slightly volatile
Long Term Debt6.1 B5.8 B3.4 B
Slightly volatile
Net Receivables76.6 B72.9 B38.7 B
Slightly volatile
Short Term Investments10.7 B10.2 B4.6 B
Slightly volatile
Inventory38.5 B36.6 B20.1 B
Slightly volatile
Other Current Assets1.5 B1.4 B2.2 B
Slightly volatile
Total Liabilities138.2 B131.6 B67.1 B
Slightly volatile
Intangible Assets6.7 B6.4 B4.5 B
Slightly volatile
Common Stock4.5 B4.3 B2.9 B
Slightly volatile
Property Plant Equipment19.1 B18.2 B9.9 B
Slightly volatile
Other Liabilities4.8 B4.5 B2.3 B
Slightly volatile
Good Will7.3 B11.4 B7.1 B
Slightly volatile
Net Tangible Assets28.6 B36.9 B26.4 B
Slightly volatile
Deferred Long Term Liabilities504.8 M394 M380.3 M
Slightly volatile
Long Term Investments5.1 B6.2 B4.7 B
Slightly volatile
Short and Long Term Debt21 B35.6 B12.9 B
Slightly volatile
Total Current Assets111.5 B162.4 B86.7 B
Slightly volatile
Short Term Debt14.5 B26.6 B11.8 B
Slightly volatile
Non Current Assets Total42.3 B49.5 B32.3 B
Slightly volatile
Non Currrent Assets Other418.7 M440.7 M1.7 B
Pretty Stable
Non Current Liabilities Total9.9 B9.3 B7.4 B
Slightly volatile
Non Current Liabilities Other274.1 M250.1 M200.4 M
Slightly volatile
Net Debt9.3 B10.8 B5.4 B
Slightly volatile
Common Stock Shares Outstanding3.4 B3.7 B2.9 B
Slightly volatile
Net Invested Capital86.3 B109.9 B66.1 B
Slightly volatile
Net Working Capital29.9 B40.1 B23.5 B
Slightly volatile
Capital Stock3.4 B3.7 B3 B
Slightly volatile
Property Plant And Equipment Net16.8 B17.9 B13.8 B
Slightly volatile
Capital Lease Obligations1.5 B1.6 B1.3 B
Slightly volatile
Property Plant And Equipment Gross15.5 B17.9 B18.7 B
Pretty Stable

Shanghai Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative16.4 B15.6 B10.3 B
Slightly volatile
Total Revenue273.3 B260.3 B144.9 B
Slightly volatile
Operating Income10 B9.6 B5.3 B
Slightly volatile
Cost Of Revenue240.4 B229 B125.9 B
Slightly volatile
Income Before Tax7.4 B7.1 B5.2 B
Slightly volatile
Net Income Applicable To Common Shares6.2 B5.9 B3.6 B
Slightly volatile
Net Income2.2 B3.8 B3.2 B
Slightly volatile
Income Tax Expense2.2 B2.1 B1.2 B
Slightly volatile
Research Development1.1 B2.2 B1 B
Slightly volatile
Gross Profit25.7 B31.3 B19.9 B
Slightly volatile
Other Operating Expenses503.2 M728.2 M449.6 M
Slightly volatile
Net Income From Continuing Ops5.4 B5.2 B4.5 B
Slightly volatile
EBIT6.6 B8.6 B5.5 B
Slightly volatile
Total Operating Expenses188.4 B250.7 B149.3 B
Slightly volatile
Tax Provision1.6 B1.9 B1.2 B
Slightly volatile
Interest Income315.1 M461.8 M242.6 M
Slightly volatile
EBITDA10.7 B14.6 B8.8 B
Slightly volatile
Reconciled Depreciation1.8 B2.2 B1.3 B
Slightly volatile

Shanghai Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Dividends Paid4.2 B4 B2 B
Slightly volatile
Capital Expenditures3.1 B3 B2 B
Slightly volatile
Total Cash From Operating Activities5.5 B5.2 B3.2 B
Slightly volatile
Net Income2.2 B3.8 B3.2 B
Slightly volatile
Other Cashflows From Investing Activities572.4 M697.3 M607.2 M
Slightly volatile
Net Borrowings2.4 B2.9 B2.7 B
Pretty Stable
Depreciation1.7 B2.2 B1.3 B
Slightly volatile
Change To Netincome1.4 B1.2 B984.5 M
Slightly volatile
Change To Liabilities15.1 B14.4 B5 B
Slightly volatile
Change To Operating Activities680 M583.9 M1.1 B
Slightly volatile
End Period Cash Flow20.4 B27.5 B15.7 B
Slightly volatile
Free Cash Flow2.2 B2.3 B1.4 B
Slightly volatile
Begin Period Cash Flow19 B24.5 B14.5 B
Slightly volatile
Other Non Cash Items1.7 B2.1 B1.3 B
Slightly volatile
Issuance Of Capital Stock2.1 B2.4 B2.6 B
Slightly volatile

Shanghai Fundamental Market Drivers

Forward Price Earnings18.4162

About Shanghai Pharmaceuticals Financial Statements

Shanghai Pharmaceuticals stakeholders use historical fundamental indicators, such as Shanghai Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Shanghai Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Shanghai Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Shanghai Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Shanghai Pharmaceuticals Holding. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue260.3 B273.3 B
Cost Of Revenue229 B240.4 B

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Shanghai Stock

Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY